Federated Hermes’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $15.8K | Sell |
|
|||||
|
2025
Q2 | $182K | Sell |
|
|||||
|
2025
Q1 | $2.11M | Buy |
|
|||||
|
2024
Q4 | $2.68M | Sell |
|
|||||
|
2024
Q3 | $5.94M | Sell |
|
|||||
|
2024
Q2 | $8.07M | Sell |
|
|||||
|
2024
Q1 | $12.8M | Sell |
|
|||||
|
2023
Q4 | $17.8M | Sell |
|
|||||
|
2023
Q3 | $15M | Sell |
|
|||||
|
2023
Q2 | $21.8M | Buy |
|
|||||
|
2023
Q1 | $21.9M | Buy |
|
|||||
|
2022
Q4 | $25.6M | Buy |
|
|||||
|
2022
Q3 | $20.8M | Buy |
|
|||||
|
2022
Q2 | $18.5M | Buy |
|
|||||
|
2022
Q1 | $12.6M | Buy |
|
|||||
|
2021
Q4 | $11.8M | Buy |
|
|||||
|
2021
Q3 | $11.8M | Buy |
|
|||||
|
2021
Q2 | $8.71M | Buy |
|
|||||
|
2021
Q1 | $1.7M | Hold |
|
|||||
|
2020
Q4 | $2.01M | Buy |
|